Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Biologic agents in juvenile spondyloarthropathies.

Katsicas MM, Russo R.

Pediatr Rheumatol Online J. 2016 Mar 12;14(1):17. doi: 10.1186/s12969-016-0076-6. Review.

2.

Evaluation and Treatment of Childhood Enthesitis-Related Arthritis.

Gmuca S, Weiss PF.

Curr Treatm Opt Rheumatol. 2015 Dec;1(4):350-364. Epub 2015 Sep 19. No abstract available.

3.

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis.

Burgos-Vargas R, Tse SM, Horneff G, Pangan AL, Kalabic J, Goss S, Unnebrink K, Anderson JK.

Arthritis Care Res (Hoboken). 2015 Nov;67(11):1503-12. doi: 10.1002/acr.22657.

4.

Juvenile spondyloarthritis.

Gmuca S, Weiss PF.

Curr Opin Rheumatol. 2015 Jul;27(4):364-72. doi: 10.1097/BOR.0000000000000185. Review.

5.

Etanercept biosimilars.

Azevedo VF, Galli N, Kleinfelder A, D'Ippolito J, Urbano PC.

Rheumatol Int. 2015 Feb;35(2):197-209. doi: 10.1007/s00296-014-3080-5. Epub 2014 Jul 1. Review.

6.

Treatment of juvenile idiopathic arthritis: a revolution in care.

Stoll ML, Cron RQ.

Pediatr Rheumatol Online J. 2014 Apr 23;12:13. doi: 10.1186/1546-0096-12-13. eCollection 2014. Review.

7.

Update on juvenile spondyloarthritis.

Ramanathan A, Srinivasalu H, Colbert RA.

Rheum Dis Clin North Am. 2013 Nov;39(4):767-88. doi: 10.1016/j.rdc.2013.06.002. Epub 2013 Aug 24. Review.

8.

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2014 Jun;73(6):1114-22. doi: 10.1136/annrheumdis-2012-203046. Epub 2013 May 21.

9.

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, Thon A, Borte M, Ganser G, Trauzeddel R, Huppertz HI.

Arthritis Res Ther. 2012 Oct 24;14(5):R230. doi: 10.1186/ar4072.

10.

Juvenile spondyloarthritis treatment recommendations.

Tse SM, Burgos-Vargas R, Colbert RA.

Am J Med Sci. 2012 May;343(5):367-70. doi: 10.1097/MAJ.0b013e3182514043.

11.

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.

Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, Delzell E, Saag KG, Solomon DH, Lewis JD; Safety Assessment of Biological Therapeutics Collaboration.

Arthritis Rheum. 2012 Apr;64(4):1263-71. doi: 10.1002/art.34348. Epub 2012 Feb 10.

12.
13.

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N.

Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460. Review. No abstract available.

14.

Challenges in the management of juvenile idiopathic arthritis with etanercept.

Pain CE, McCann LJ.

Biologics. 2009;3:127-39. Epub 2009 Jul 13.

16.

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER.

Carmona L, Gómez-Reino JJ; BIOBADASER Group.

Arthritis Res Ther. 2006;8(3):R72. Epub 2006 Apr 18.

Supplemental Content

Support Center